Jump Financial LLC Has $13.30 Million Stock Position in Danaher Co. (NYSE:DHR)

Jump Financial LLC raised its position in Danaher Co. (NYSE:DHR - Free Report) by 504.1% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 57,941 shares of the conglomerate's stock after buying an additional 48,350 shares during the quarter. Jump Financial LLC's holdings in Danaher were worth $13,300,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in DHR. Kentucky Retirement Systems Insurance Trust Fund increased its stake in Danaher by 11.6% during the 4th quarter. Kentucky Retirement Systems Insurance Trust Fund now owns 21,233 shares of the conglomerate's stock worth $4,874,000 after acquiring an additional 2,202 shares during the period. ORG Partners LLC increased its position in shares of Danaher by 1,212.8% in the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate's stock worth $636,000 after purchasing an additional 2,559 shares during the period. Generate Investment Management Ltd acquired a new position in Danaher in the fourth quarter valued at about $8,044,000. Compass Capital Management Inc. lifted its position in Danaher by 4.8% during the fourth quarter. Compass Capital Management Inc. now owns 237,922 shares of the conglomerate's stock worth $54,615,000 after purchasing an additional 10,994 shares during the period. Finally, Channing Global Advisors LLC grew its stake in Danaher by 42.8% during the fourth quarter. Channing Global Advisors LLC now owns 5,666 shares of the conglomerate's stock worth $1,301,000 after buying an additional 1,698 shares in the last quarter. Institutional investors own 79.05% of the company's stock.

Insider Buying and Selling at Danaher

In other news, SVP Brian W. Ellis sold 5,700 shares of the company's stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 11.10% of the company's stock.

Danaher Trading Down 2.1 %

Shares of Danaher stock traded down $3.95 during midday trading on Friday, reaching $186.71. The company had a trading volume of 3,667,685 shares, compared to its average volume of 3,325,342. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. Danaher Co. has a fifty-two week low of $171.00 and a fifty-two week high of $281.70. The stock has a fifty day moving average price of $201.99 and a 200 day moving average price of $227.23. The firm has a market cap of $133.44 billion, a PE ratio of 35.36, a P/E/G ratio of 2.66 and a beta of 0.86.

Danaher (NYSE:DHR - Get Free Report) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 EPS for the quarter, meeting analysts' consensus estimates of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the previous year, the company earned $2.09 EPS. On average, equities analysts anticipate that Danaher Co. will post 7.63 earnings per share for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Friday, March 28th will be paid a $0.32 dividend. The ex-dividend date is Friday, March 28th. This is a positive change from Danaher's previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a yield of 0.69%. Danaher's payout ratio is 24.24%.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on DHR. Jefferies Financial Group cut their price target on shares of Danaher from $285.00 to $260.00 and set a "buy" rating for the company in a report on Wednesday, January 29th. Raymond James reaffirmed a "market perform" rating on shares of Danaher in a report on Monday, February 3rd. Robert W. Baird set a $231.00 price target on Danaher in a report on Wednesday. The Goldman Sachs Group raised Danaher from a "neutral" rating to a "buy" rating and set a $260.00 price objective on the stock in a research note on Friday, March 21st. Finally, Barclays raised Danaher from an "equal weight" rating to an "overweight" rating and lowered their target price for the stock from $240.00 to $205.00 in a research note on Thursday, April 10th. Four research analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $274.55.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.